BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 25, 2001
View Archived Issues
MorphoSys and ImmunoGen expand HuCAL collaboration
Read More
Selective VPAC2 receptor agonists hold potential for type 2 diabetes Rx
Read More
Very long-acting human insulin analogue presented by Novo Nordisk at ADA meeting
Read More
DPP-IV inhibitor improves metabolic control in type 2 diabetes
Read More
Safety of single and multiple doses of NBI-6024 demonstrated in type 1 diabetics
Read More
AT-1015, a 5-HT2 antagonist, improves nerve blood flow and sensory/motor deficits in diabetic rats
Read More
ADA news: preclinical findings support potential of FK-614 in type 2 diabetes
Read More
Initiation of phase III trials of TSE-424 triggers milestone payment from Wyeth to Ligand
Read More
NN-2211: preclinical and clinical data discussed at ADA scientific sessions
Read More
Corixa and Kirin form alliance for therapeutic monoclonal antibodies
Read More
Yasmin now available in the U.S.
Read More
Atovaquone nanosuspensions have excellent therapeutic efficacy in toxoplasmosis
Read More
AstraZeneca's Zomig approved in Japan for migraine
Read More
FDA issues nonapprovable letter to Wyeth-Ayerst for long-bone fracture therapy
Read More
DepoMed commences phase III trial of Metformin GR for type 2 diabetes
Read More
Nortran's antiarrhythmic agent shows oral bioavailability
Read More
Kosan Biosciences awarded SBIR grant for epothilone development
Read More
UroGenesys changes name to Agensys
Read More
NAVIGATOR trial to study nateglinide/valsartan for diabetes and cardiovascular disease prevention
Read More
Results for Vasogen's immune modulation therapy to be presented in September
Read More
Prous Science launches Integrity --the world's first integrated drug discovery portal
Read More
Heterocyclic compounds useful as medicines described by SCRAS
Read More
Methods of inhibiting ApoB secretion and/or inhibiting MTP patented by Pfizer
Read More
Japan Energy identifies protease inhibitors for HCV
Read More
Japanese labs collaborate on discovery of new TPO receptor ligands
Read More
Sphingomyelinase inhibitors discovered in natural sources at Kitasato Institute
Read More